Find a Programme

UK NEQAS provides External Quality Assessment/Proficiency Testing for all major aspects of clinical laboratory testing. To find the programme(s) to match your EQA/PT requirements please use the search function below.

Showing Results: 196 - 210 out of 446

Haematinics

|

Clinical Chemistry (Birmingham Quality)

Assessment of analytical bias and its consistency across time

More Information

Haematological Malignancy Bone Marrow Aspirate Assessment (Pilot)

|

Leucocyte Immunophenotyping

More Information

Haematological Technical FISH

|

Genomics (GenQA)

Analysis for detection of recurrent translocations and copy number changes in leukaemia: fixed cell suspensions for interphase FISH studies.

More Information

Haemoglobin only

|

Haematology

To monitor the performance of instruments providing Hb concentration only, including blood gas analysers and point-of-care analysers


HBV DNA quantification

|

Microbiology

To provide EQA for laboratories determining levels of HBV DNA

More Information

Heparin Assay (HA) - anti-Xa

|

Blood Coagulation

More Information

Heparin Dosage Assessment (HDA) by APTT

|

Blood Coagulation

More Information

Hepatitis A detection

|

Microbiology

More Information

Hepatitis B serology

|

Microbiology

To provide EQA for laboratories determining infectious status with HBV

More Information

Hepatitis C RNA detection

|

Microbiology

To provide EQA for laboratories determining levels of HCV RNA and genotype of HCV

More Information

Hepatitis C serology

|

Microbiology

To provide EQA for laboratories determining evidence of exposure to HCV

More Information

Hepatitis E detection

|

Microbiology

To determine HEV IgM and IgG status in human serum

More Information

Hereditary breast and ovarian cancer disorders (HBOC)

|

Genomics (GenQA)

Molecular testing for disorders associated with HBOC.

More Information

HFE Typing (Scheme 5A)

|

Histocompatibility & Immunogenetics

To assess participants' ability to correctly determine HFE mutations

More Information

High-risk HPV in Head & Neck Pathology (Pilot)

|

Immunocytochemistry & In-Situ Hybridisation

More Information

1 12 13 14 15 16 30